Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HOWARD J RUBENSTEIN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1376598086
CMS profile
244149
Location
SARALAND, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,424.94

82 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,345.14 80
Gift $59.40 1
Education $20.40 1

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HOWARD J RUBENSTEIN

NPI 1376598086 · CMS profile ID 244149

Allopathic & Osteopathic Physicians / Family Medicine

SARALAND, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1376598086?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1376598086?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1376598086?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 82 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1376598086?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

82 matching records · $1,424.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 82 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 82.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
IDORSIA PHARMACEUTICALS US INC $18.6512/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942809281 CMS
Currax Pharmaceuticals LLC $13.7612/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925767985 CMS
IDORSIA PHARMACEUTICALS US INC $17.1511/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942816727 CMS
ABBVIE INC. $6.5211/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488407 CMS
ABBVIE INC. $14.8811/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488409 CMS
Novo Nordisk Inc $0.8911/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899061797 CMS
Novo Nordisk Inc $5.3511/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899061805 CMS
Novartis Pharmaceuticals Corporation $18.4611/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894303291 CMS
GlaxoSmithKline, LLC. $11.8411/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944925179 CMS
Kowa Pharmaceuticals America, Inc. $12.4811/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900438435 CMS
Novo Nordisk Inc $4.9511/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898964069 CMS
Novo Nordisk Inc $1.9611/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899014943 CMS
Merck Sharp & Dohme LLC $22.6910/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944501785 CMS
Lilly USA, LLC $15.0910/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918069805 CMS
Dexcom, Inc. $12.5010/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957295093 CMS
Biohaven Pharmaceutical Holding Company Ltd. $17.7910/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923718069 CMS
Merck Sharp & Dohme LLC $16.1910/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944501383 CMS
Novo Nordisk Inc $5.2810/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899443511 CMS
Novo Nordisk Inc $1.8310/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899522927 CMS
Novo Nordisk Inc $0.6610/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899061915 CMS
ABBVIE INC. $29.8709/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488405 CMS
Novo Nordisk Inc $17.4509/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899522935 CMS
Novo Nordisk Inc $2.0509/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899443509 CMS
ABBVIE INC. $13.7709/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488403 CMS
Xeris Pharmaceuticals, Inc. $23.0609/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946478005 CMS
AstraZeneca Pharmaceuticals LP $117.6409/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915886641 CMS
Biohaven Pharmaceutical Holding Company Ltd. $11.9209/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923718067 CMS
Novo Nordisk Inc $2.2109/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898638103 CMS
Novo Nordisk Inc $3.6409/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898638111 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.8709/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959655795 CMS
ABBVIE INC. $11.2408/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488401 CMS
ABBVIE INC. $11.4208/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488399 CMS
Novo Nordisk Inc $14.2308/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898916736 CMS
Amgen Inc. $14.9708/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939282619 CMS
Amgen Inc. $13.0908/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939282615 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.1708/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 960006865 CMS
ABBVIE INC. $5.3007/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488397 CMS
Bayer HealthCare Pharmaceuticals Inc. $13.4407/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930254253 CMS
AstraZeneca Pharmaceuticals LP $12.6007/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915419723 CMS
ABBVIE INC. $9.6307/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488395 CMS
Novo Nordisk Inc $2.2607/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898916729 CMS
Novo Nordisk Inc $4.8207/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899014951 CMS
ABBVIE INC. $18.8307/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488393 CMS
Lilly USA, LLC $17.8907/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918038157 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.3307/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959696939 CMS
AstraZeneca Pharmaceuticals LP $12.6106/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915603583 CMS
Dexcom, Inc. $12.5006/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957295095 CMS
ABBVIE INC. $22.5406/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488387 CMS
ABBVIE INC. $1.0806/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488389 CMS
ABBVIE INC. $7.6406/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891488391 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,704.05 108
PY2020 $792.39 63
PY2021 $1,250.93 61
PY2022 $1,424.94 82
PY2023 $2,008.26 62
PY2025 $1,028.79 6

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $290,410.38 20
PY2024 Principal investigator $582,175.45 67
PY2023 Principal investigator $178,596.47 28
PY2022 Principal investigator $323,131.01 30
PY2021 Principal investigator $410,276.56 30
PY2020 Recipient $1,694.65 7
PY2020 Principal investigator $897,181.33 26
PY2019 Principal investigator $623,481.03 21

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

30 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Allergan, Inc. $198.44 12/31/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS INCORPORATED
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 789013069
Principal investigator 1 Allergan, Inc. $1,179.22 12/31/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS INCORPORATED
CHRONIC IDIOPATHIC CONSTIPATION (CIC),IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) No dispute reported 06/30/2026 789013071
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,328.92 12/31/2021 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler No dispute reported 06/30/2026 826480939
Principal investigator 1 CHIESI USA, INC. $951.90 11/19/2021 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
Not supplied No dispute reported 06/30/2026 849319233
Principal investigator 1 Allergan, Inc. $3,021.00 11/12/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013065
Principal investigator 1 Allergan, Inc. $969.95 11/12/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013067
Principal investigator 1 Allergan, Inc. $3,021.00 10/13/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013063
Principal investigator 1 Allergan, Inc. $6,866.60 09/14/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013059
Principal investigator 1 Allergan, Inc. $2,470.95 09/14/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013061
Principal investigator 1 Allergan, Inc. $9,215.00 08/13/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013055
Principal investigator 1 Allergan, Inc. $4,798.45 08/13/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013057
Principal investigator 1 Allergan, Inc. $1,195.10 07/13/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013051
Principal investigator 1 Allergan, Inc. $4,859.25 07/13/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013053
Principal investigator 1 Novartis Pharmaceuticals Corporation $13,384.96 06/23/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS INC
AN OPEN-LABEL EXTENSION TRIAL OF THE PHASE III LIPID-LOWERING TRIALS TO ASSESS THE EFFECT OF LONG TERM DOSING OF INCLISIRAN GIVEN AS SUBCUTANEOUS INJECTIONS IN SUBJECTS WITH HIGH CARDIOVASCULAR RISK AND ELEVATED LDL-C No dispute reported 06/30/2026 965470143
Principal investigator 1 Allergan, Inc. $1,510.50 06/15/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013047
Principal investigator 1 Allergan, Inc. $4,941.90 06/15/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013049
Principal investigator 1 Allergan, Inc. $4,849.75 05/17/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013045
Principal investigator 1 Allergan, Inc. $1,716.65 05/13/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013043
Principal investigator 1 Allergan, Inc. $2,850.00 04/19/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013041
Principal investigator 1 Allergan, Inc. $5,970.75 04/16/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013039
Principal investigator 1 Allergan, Inc. $3,297.45 04/13/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013037
Principal investigator 1 AstraZeneca Pharmaceuticals LP $32,407.52 04/07/2021 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler No dispute reported 06/30/2026 826463903
Principal investigator 1 Allergan, Inc. $7,666.50 03/16/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013033
Principal investigator 1 Allergan, Inc. $4,849.75 03/16/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013035
Principal investigator 1 Allergan, Inc. $1,950.35 02/15/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013029
Principal investigator 1 Allergan, Inc. $10,279.95 02/15/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013031
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $191,560.60 01/26/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS INC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL OF FIXED-DOSE BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN THE TREATMENT OF ADULTS WITH POST-TRAUMATIC STRESS DISORDER No dispute reported 06/30/2026 844172071
Principal investigator 1 Allergan, Inc. $3,685.05 01/18/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 789013027
Principal investigator 1 Allergan, Inc. $8,447.40 01/14/2021 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALSINC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 789013025
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $66,831.70 01/14/2021 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
AN OPEN-LABEL, 52-WEEK, MULTICENTER TRIAL EVALUATING THE LONG-TERM SAFETY AND TOLERABILITY OF CENTANAFADINE SUSTAINED-RELEASE TABLETS IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER No dispute reported 06/30/2026 844171469